Torres de Melo Bezerra Girão Adriana, Torres de Melo Bezerra Cavalcante Candice, Pereira Castello Branco Klebia Magalhães, Consuelo de Oliveira Teles Andrea, Libório Alexandre Braga
Medical Sciences Postgraduate Program, Universidade de Fortaleza-UNIFOR, Fortaleza, Brazil.
Hospital do Coração de Messejana, Fortaleza, Brazil.
Clin J Am Soc Nephrol. 2024 Oct 1;19(10):1230-1239. doi: 10.2215/CJN.0000000000000534. Epub 2024 Jul 26.
Using indwelling urinary catheters, urine output (UO) shows good performance in neonates and younger children. Using higher UO thresholds in neonates post-cardiac surgery improves discriminatory capacity for outcomes compared to neonatal Kidney Disease Improving Global Outcomes. In younger children (1–24 months), higher UO thresholds were not better than the adult Kidney Disease Improving Global Outcomes criteria.
Pediatric AKI is associated with significant morbidity and mortality, yet a precise definition, especially concerning urine output (UO) thresholds, remains unproven. We evaluate UO thresholds for AKI in neonates and children aged 1–24 months with indwelling urinary catheters undergoing cardiac surgery.
A 6-year prospective cohort study (2018–2023) after cardiac surgery was conducted at a reference center in Brazil. All patients had indwelling urinary catheters up to 48 hours after surgery and at least two serum creatinine measurements, including one before surgery. The main objective of this study was to determine the optimal UO thresholds for AKI definition and staging in neonates and younger children compared with the currently used criteria—neonatal and adult Kidney Disease Improving Global Outcomes (KDIGO) definitions. The outcome was a composite of severe AKI (stage 3 AKI diagnosed by the serum creatinine criterion only), KRT, or hospital mortality.
The study included 1024 patients: 253 in the neonatal group and 772 in the younger children group. In both groups, the lowest UO at 24 hours as a continuous variable had good discriminatory capacity for the composite outcome (area under the curve-receiver operating characteristic 0.75 [95% confidence interval, 0.70 to 0.81] and 0.74 [95% confidence interval, 0.68 to 0.79]). In neonates, the best thresholds were 3.0, 2.0, and 1.0 ml/kg per hour, and in younger children, the thresholds were 1.8, 1.0, and 0.5 ml/kg per hour. These values were used for modified AKI staging for each age group. In neonates, this modified criterion was associated with the best discriminatory capacity (area under the curve-receiver operating characteristic 0.74 [0.67 to 0.80] versus 0.68 [0.61 to 0.75], < 0.05) and net reclassification improvement in comparison with the neonatal KDIGO criteria. In younger children, the modified criteria had good discriminatory capacity but were comparable with the adult KDIGO criteria, and the net reclassification improvement was near zero.
Using indwelling catheters for UO measurements, our study reinforced that the current KDIGO criteria may require adjustments to better serve the neonate population. In addition, using the UO criteria, we validated the adult KDIGO criteria in children aged 1–24 months.
使用留置导尿管时,尿量(UO)在新生儿和年幼儿童中表现良好。与新生儿改善全球肾脏病预后组织(KDIGO)的标准相比,心脏手术后新生儿采用更高的尿量阈值可提高对预后的判别能力。在年幼儿童(1 - 24个月)中,更高的尿量阈值并不优于成人KDIGO标准。
儿童急性肾损伤(AKI)与显著的发病率和死亡率相关,但精确的定义,尤其是关于尿量(UO)阈值,仍未得到证实。我们评估了接受心脏手术并使用留置导尿管的1 - 24个月的新生儿和儿童AKI的尿量阈值。
在巴西的一个参考中心进行了一项心脏手术后的6年前瞻性队列研究(2018 - 2023年)。所有患者术后留置导尿管48小时,并至少进行两次血清肌酐测量,包括术前一次。本研究的主要目的是确定与目前使用的标准——新生儿和成人KDIGO定义相比,新生儿和年幼儿童AKI定义及分期的最佳尿量阈值。结局指标为严重AKI(仅根据血清肌酐标准诊断为3期AKI)、肾脏替代治疗(KRT)或医院死亡率的复合指标。
该研究纳入1024例患者:新生儿组253例,年幼儿童组772例。在两组中,24小时时最低尿量作为连续变量对复合结局具有良好的判别能力(曲线下面积 - 受试者工作特征曲线分别为0.75 [95%置信区间,0.70至0.81]和0.74 [95%置信区间,0.68至0.79])。在新生儿中,最佳阈值分别为每小时3.0、2.0和1.0 ml/kg,在年幼儿童中,阈值分别为每小时1.8、1.0和0.5 ml/kg。这些值用于各年龄组的改良AKI分期。在新生儿中,与新生儿KDIGO标准相比,这种改良标准具有最佳的判别能力(曲线下面积 - 受试者工作特征曲线为0.74 [0.67至0.80]对0.68 [0.61至0.75],P < 0.05)和净重新分类改善。在年幼儿童中,改良标准具有良好的判别能力,但与成人KDIGO标准相当,净重新分类改善接近零。
使用留置导尿管测量尿量,我们的研究强调当前的KDIGO标准可能需要调整以更好地适用于新生儿群体。此外,使用尿量标准,我们验证了成人KDIGO标准在1 - 24个月儿童中的适用性。